Detalles de la búsqueda
1.
Varying Willingness to Pay Based on Severity of Illness: Impact on Health Technology Assessment Outcomes of Inpatient and Outpatient Drug Therapies in The Netherlands.
Value Health
; 25(1): 91-103, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031104
2.
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC: A US Healthcare Perspective.
J Natl Compr Canc Netw
; 19(2): 153-162, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545688
3.
Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma.
BMC Cancer
; 16: 598, 2016 08 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488675
4.
Quality of life improvement in patients treated with degarelix versus leuprorelin for advanced prostate cancer.
J Urol
; 193(3): 839-46, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25264336
5.
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.
Pharmacoecon Open
; 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38289517
6.
Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model.
Front Med Technol
; 5: 1010247, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36860906
7.
Cost Effectiveness of Durvalumab in Unresectable Stage III NSCLC: 4-Year Survival Update and Model Validation from a UK Healthcare Perspective.
Pharmacoecon Open
; 6(2): 241-252, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34532842
8.
Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.
Pharmacoecon Open
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717555
9.
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK.
Pharmacoeconomics
; 36(8): 1015-1027, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797186
10.
Cost-effectiveness of renal denervation therapy for the treatment of resistant hypertension in The Netherlands.
J Med Econ
; 18(1): 76-87, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25367314
11.
Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?
PLoS One
; 8(8): e70319, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23950920
Resultados
1 -
11
de 11
1
Próxima >
>>